Search

Your search keyword '"Omapatrilat"' showing total 5 results
Start Over Descriptor "Omapatrilat" Database Gale General OneFile
5 results on '"Omapatrilat"'

3. Patent Issued for Crystalline Form Of Benzylbenzene SGLT2 Inhibitor (USPTO 10,533,032)

Subjects
Antihypertensive agents, Tezosentan -- Intellectual property, Angiotensin II receptor blockers, Oxcarbazepine, Hypoglycemic agents, Perindopril, Clopidogrel -- Intellectual property, Midostaurin -- Intellectual property, Cilostazol -- Intellectual property, Lofexidine -- Intellectual property, Torsemide -- Intellectual property, Adrenergic beta-antagonists, Type 2 diabetes, Thiazides -- Intellectual property, Calcium channel blockers -- Intellectual property, Antiarrhythmia agents -- Intellectual property, Anopheles, Ambrisentan, Olmesartan medoxomil, Liraglutide, Methyclothiazide, Obesity, Alogliptin, Nebivolol, Exenatide, Eprosartan, Lercanidipine, Penbutolol, Esmolol, Editors, Hydrochlorothiazide, Indapamide, Saxagliptin, Valsartan, Trichlormethiazide, Sitagliptin, Sitaxsentan, Pindolol, Hydroflumethiazide, Omapatrilat, Telmisartan, Fosinopril, Carteolol, Miglitol, Nisoldipine, Bosentan, Bepridil, Health
Abstract

2020 JAN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- Theracos Sub LLC (Marlborough, Massachusetts, United States) has been issued patent number 10,533,032, [...]

Published
2020

4. Researchers Submit Patent Application, 'New Use', for Approval (USPTO 20190022063)

Subjects
Novartis AG -- Intellectual property, Pharmaceutical industry -- Intellectual property, Angiotensin II, Omapatrilat, Hypertension, Sacubitril, Valsartan, Cardiovascular diseases, Editors, Business, Health
Abstract

2019 FEB 15 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors [...]

Published
2019

5. New Angioedema Findings from R.M. McKinnell and Co-Researchers Described [Discovery of TD-0212, an Orally Active Dual Pharmacology AT1 Antagonist and Neprilysin Inhibitor (ARNI)]

Subjects
Angiotensin II, Angioneurotic edema, Omapatrilat, Medical research, Angiotensins, Skin, Bradykinin, Skin diseases, Pharmacology, Editors, Health, American Chemical Society
Abstract

2019 FEB 4 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Current study results on Vascular Skin Diseases and Conditions - Angioedema have been published. According [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results